Life Science Platform Delivers Real Time, Comprehensive and Seamless
and Proprietary Biological Sequence, Interaction and Patent Information
PHILADELPHIA, Sept. 10 /CNW/ -- Thomson Scientific, part of The Thomson
Corporation (NYSE: TOC; TSX: TOC) and leading provider of information
solutions to the worldwide research and business communities, announced today
the release of BONDplus, an integrated, web-based data platform to address the
information and analytic needs of biological researchers.
Compiled from 15 assembled resources including GenBank, RefSeq, Entrez
Gene and UniProtKB/Swiss-Prot, BONDplus allows researchers to move beyond the
genome and leverage publicly available biological sequence data, BINDplus
biomolecular interaction data as well as GENESEQ, a value added database of
patented biological sequences. The platform allows novel insights into
biological research including target-based discovery and rational drug design.
"Today's life science data management faces considerable hurdles due to
years of fragmented and non-standardized production of biological data," said
Jon Brett-Harris, executive vice president of pharmaceutical and chemical
markets at Thomson Scientific. "Since solutions are frequently focused on one
data type or in a niche area, an integrated platform can provide a distinct
competitive advantage, allowing scientists not only to access public domain
data, but also to integrate their own proprietary data and value-added Thomson
Scientific data in a consistent and user-friendly format."
BONDplus provides an intuitive and value-added resource for any
researcher by uniting the genomic, proteomic and metabolomic research
communities around one comprehensive platform. The subscription service
provides information from over 15 assembled resources including BINDplus and
GENESEQ in addition to pre- computed data sets with BLAST functionality,
visualization tools and over 80 million in public domain sequences.
A leading provider of life science research information, Thomson serves
primary, secondary and tertiary data types, ranging from proteins and small
molecules to gene and protein expression and more complex data types such as
toxicology/efficacy data, biomarker, interaction and pathway information.
For more information on BONDplus, please visit:
About The Thomson Corporation
The Thomson Corporation (www.thomson.com) is a global leader in providing
essential electronic workflow solutions to business and professional
customers. With operational headquarters in Stamford, Conn., Thomson provides
value-added information, software tools and applications to professionals in
the fields of law, tax, accounting, financial services, scientific research
and healthcare. The Corporation's common shares are listed on the New York
and Toronto stock exchanges (NYSE: TOC; TSX: TOC).
Thomson Scientific is a business of The Thomson Corporation. Its
information solutions assist professionals at every stage of research and
development-from discovery to analysis to product development and
distribution. Thomson Scientific information solutions can be found at
For further information:
For further information: Allison Hagan of Thomson Scientific,
+1-215-823-1881, email@example.com Web Site: